Kezar Life Sciences Inc.

5.70
-0.01 (-0.18%)
At close: Mar 03, 2025, 3:59 PM
5.70
0.00%
After-hours: Mar 03, 2025, 04:00 PM EST

Kezar Life Sciences Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -67.45 -726.13 -1.66K -589.13 -242.7 -1.05K -2.71K -2.57K
PEG Ratio -1.52 183.35 -122.8 12.79 8.99 -4.22 468.09 n/a
PS Ratio 981.55 n/a n/a n/a n/a n/a n/a n/a
PB Ratio 36.63 175.74 448.07 162.93 98.05 222.66 -899.73 -1.33K
P/FCF Ratio -82.33 -784.92 -2.06K -618.43 -251.04 -1.11K -2.72K -2.34K
P/OCF Ratio -84.15 -805.96 -2.08K -621.67 -256.14 -1.17K -2.85K -2.37K
OCF/S Ratio -11.66 n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.10 0.08 0.07 0.04 0.08 n/a n/a n/a
Quick Ratio 11.66 25.98 25.47 22.17 13.31 32.91 35.26 16.11
Current Ratio 11.66 25.98 25.77 22.48 13.52 32.91 35.26 16.11
Asset Turnover 0.03 n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -67.89 -60.05 -343.77 n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.54 -0.24 -0.27 -0.28 -0.4 -0.21 0.33 0.52
Return on Assets (ROA) -0.46 -0.22 -0.24 -0.26 -0.35 -0.2 -0.16 -0.79
Return on Capital (ROIC) -0.52 -0.25 -0.26 -0.3 -0.45 -0.22 -0.17 -0.83
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 84.77% n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin -1.46K% n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin -1.46K% n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin -1.5K% n/a n/a n/a n/a n/a n/a n/a
FCF Margin -1.19K% n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin -1.42K% n/a n/a n/a n/a n/a n/a n/a